Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Futures Intelligence

Index Tracker: Crisis and correlations: the managed futures exception.

Monday, September 20, 2010

Crisis and Correlations

Academic research on the market events of the past three years largely confirms investors' experience. Here is another perspective on the performance of various asset classes before and during the financial crisis, from a study by Edward Szado, sponsored by the Chicago Board Options Exchange.

Mr. Szado points out that correlations between equities, bonds and alternative investments tended to be relatively low before the crisis but rose significantly in 2007 and 2008 as the assets lost value. "As a result, many investors discovered that portfolios which they believed to be well diversified based on historical data, were effectively not diversified at all," he says.

He shows that correlations between alternative investments and the stock market were significantly higher in 2007-2008 than in the earlier period. Most alternatives fell into this pattern, with correlations rising to 80% or more for hedge funds, private equity and real estate (see chart). The notable exception was managed futures, which became less correlated to stocks as other assets became more correlated!


CHART
------------------------------------------------------------------------------------------------------------------------------------------------------
Correlation to Stocks Before and During Financial Crisis*

Period

2004-2006

2007-2008

 

 

 

Real Estate

56%

85%

Private Equity

77%

84%

Commodities

-22%

52%

Hedge Funds

77%    

80%

Managed Futures

52%

-22%

* Stocks are represented by the S&P 500, real estate by the S&P US REIT Total Return Index, private equity by the S&P Listed Private Equity Index, commodities by the S&P GSCI Total Return Index, hedge funds by the investable HFRX Global Hedge Fund Index and managed futures by the Newedge CTA Index.

SOURCE: "VIX Futures and Options - A Case Study of Portfolio Diversification During the 2008 Financial Crisis" by Edward Szado, August 2009.
------------------------------------------------------------------------------------------------------------------------------------------------------

Mr. Szado's main point is that the volatility index VIX rose sharply at the same time as almost all asset classes (with the exception of managed futures) fell and that therefore going long VIX futures would have effectively diversified conventional portfolios during the crisis. Of course, managed futures has a similar benefit.


VIX is not the only indicator of market commotion. State Street recently announced the launch of Turbulence Indexes, which measure the unusualness of daily market behavior. These cover US and European equities, currency, US fixed income and global assets. The underlying idea is that turbulence can result not only from the unusual performance of a single asset but also from the interaction between assets. It can arise from extreme movements in volatility or a sudden change in correlations among assets.

"One of the most valuable lessons learned over the last few years of market turbulence is that traditional portfolio construction techniques cannot comprehensively assess the full amount of risk inherent in a portfolio," according to Will Kinlaw, managing director and head of portfolio and risk management research at State Street Global Markets.

Institutional investors are concerned with the question of how to deal with the tendency of even alternative investments to fall into lockstep in crises, thereby spreading losses throughout supposedly diversified portfolios. It is clear that managed futures has a key role to play in meeting this challenge.
 



 
This article was published in Opalesque Futures Intelligence.
Opalesque Futures Intelligence
Opalesque Futures Intelligence
Opalesque Futures Intelligence
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for